Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
EJNMMI Research
|
March 9, 2026
Predictive value of interim ¹¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancer
Eman E Ahmed, Jack R Andrews, Mohamed E Ahmed, et al.
Biorxiv : the Preprint Server for Biology
|
July 18, 2023
<i>ent</i> -Verticilide B1 inhibits type 2 ryanodine receptor channels and is antiarrhythmic in Casq2-/- mice
Aaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Abdominal Radiology (New York)
|
June 3, 2025
Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3
Hiroaki Takahashi, Hirotsugu Nakai, Karla V Ballman, et al.
Frontiers in Oncology
|
July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapy
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
Cancer Treatment Reviews
|
April 16, 2025
Current and future directions in theranostics for neuroendocrine prostate cancer
Gokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, et al.
Molecular Pharmacology
|
January 22, 2024
<i>ent</i>-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in <i>Casq2</i> <sup>-/-</sup> Mice
Aaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Journal of Neuroinflammation
|
December 11, 2025
Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4
Georgia L Nolt, Lesley R Golden, Shealee P Thorpe, et al.
Blood Cancer Journal
|
August 17, 2023
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity
William G Breen, Jason R Young, Matthew A Hathcock, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 25, 2025
Outcomes of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, et al.
EJNMMI Research
|
March 9, 2026
Predictive value of interim ¹¹C-choline PET/CT for response to radium-223 in metastatic castration-resistant prostate cancer
Eman E Ahmed, Jack R Andrews, Mohamed E Ahmed, et al.
Biorxiv : the Preprint Server for Biology
|
July 18, 2023
<i>ent</i> -Verticilide B1 inhibits type 2 ryanodine receptor channels and is antiarrhythmic in Casq2-/- mice
Aaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Abdominal Radiology (New York)
|
June 3, 2025
Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3
Hiroaki Takahashi, Hirotsugu Nakai, Karla V Ballman, et al.
Frontiers in Oncology
|
July 29, 2024
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer <sup>177</sup>Lu-PSMA-617 therapy
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, et al.
Cancer Treatment Reviews
|
April 16, 2025
Current and future directions in theranostics for neuroendocrine prostate cancer
Gokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, et al.
Molecular Pharmacology
|
January 22, 2024
<i>ent</i>-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in <i>Casq2</i> <sup>-/-</sup> Mice
Aaron Gochman, Tri Q Do, Kyungsoo Kim, et al.
Journal of Neuroinflammation
|
December 11, 2025
Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4
Georgia L Nolt, Lesley R Golden, Shealee P Thorpe, et al.
Blood Cancer Journal
|
August 17, 2023
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity
William G Breen, Jason R Young, Matthew A Hathcock, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Page
of 14